Investor Relations

(Security Code :4506 TSE Prime)

Pick Up

May 31, 2023	Sumitomo Pharma Announces Completion of Share Transfer of Consolidated Subsidiary, Sumitomo Pharma Animal Health	Corporate
May 30, 2023	Posted Notice of Convocation of the 203rd Annual Shareholders' Meeting	Corporate
May 25, 2023	Submission of clinical trial notification for RPE tear using RPE cells derived from allogeneic iPS cells (HLCR011)	R&D
May 23, 2023	Posted Investors Meeting Presentation for FY2022 (Year ended March 31, 2023) [Webcast]	Finances
May 15, 2023	Investors Meeting Presentation for FY2022 (Year ended March 31, 2023)（PDF/672KB）	Finances
May 15, 2023	Supplementary Financial Data (IFRS) for the Year Ended March 31, 2023（PDF/302KB）	Finances

Jun. 27, 2023	203rd Annual Shareholders' Meeting